Cargando…
Severity, Pathogenicity and Transmissibility of Delta and Lambda Variants of SARS-CoV-2, Toxicity of Spike Protein and Possibilities for Future Prevention of COVID-19
The World Health Organization reports that SARS-CoV-2 has infected over 220 million people and claimed over 4.7 million lives globally. While there are new effective vaccines, the differences in behavior of variants are causing challenges in vaccine development or treatment. Here, we discuss Delta,...
Autores principales: | Moghaddar, Mehrnoosh, Radman, Ramtin, Macreadie, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540532/ https://www.ncbi.nlm.nih.gov/pubmed/34683488 http://dx.doi.org/10.3390/microorganisms9102167 |
Ejemplares similares
-
The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines
por: Mohammadi, Mehrdad, et al.
Publicado: (2021) -
Conformational changes in SARS-CoV-2 spike from the delta variant enhances viral transmissibility
por: Venkatakrishnan, Varun, et al.
Publicado: (2022) -
Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic
por: Focosi, Daniele, et al.
Publicado: (2022) -
The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines
por: Liu, Haolin, et al.
Publicado: (2021) -
Adsorption of SARS CoV-2 spike proteins on various functionalized surfaces correlates with the high transmissibility of Delta and Omicron variants
por: Dobrynin, Daniela, et al.
Publicado: (2022)